Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(R)-Azasetron besylate (SENS-401), an orally active calcineurin inhibitor, has been shown to mitigate cisplatin-induced hearing loss and cochlear damage [1][2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 127.00 |
Description | (R)-Azasetron besylate (SENS-401), an orally active calcineurin inhibitor, has been shown to mitigate cisplatin-induced hearing loss and cochlear damage [1][2]. |
Synonyms | SENS-401 |
Molecular Weight | 507.99 |
Formula | C23H26ClN3O6S |
CAS No. | 2025360-91-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(R)-Azasetron besylate 2025360-91-0 Metabolism Phosphatase SENS-401 SENS401 SENS 401 Azasetron besylate inhibitor inhibit